International Journal of Molecular Sciences · 2023 · 17 citations · 50 references
MedicineMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Stem Cell BiologyCancer Stem CellsCellular Responses To HypoxiaHypoxia AdaptationMetabolic ReprogrammingSignal Transduction In CancerChronic Myeloid Leukemia TherapyGene Ontology AnalysisHypoxia-induced MetabolismHypoxia-induced StemnessHypoxia-mediated StemnessMammalian Target Of Rapamycin SignalingMtor SignalingPi3k-akt-mtor Signaling
Hypoxia is a critical condition that governs survival, self-renewal, quiescence, metabolic shift and refractoriness to leukemic stem cell (LSC) therapy. The present study aims to investigate the hypoxia-driven regulation of the mammalian Target of the Rapamycin-2 (mTORC2) complex to unravel it as a novel potential target in chronic myeloid leukemia (CML) therapeutic strategies. After inducing hypoxia in a CML cell line model, we investigated the activities of mTORC1 and mTORC2. Surprisingly, we detected a significant activation of mTORC2 at the expense of mTORC1, accompanied by the nuclear localization of the main substrate phospho-Akt (Ser473). Moreover, the Gene Ontology analysis of CML patients' CD34+ cells showed enrichment in the mTORC2 signature, further strengthening our data. The deregulation of mTOR complexes highlights how hypoxia could be crucial in CML development. In conclusion, we propose a mechanism by which CML cells residing under a low-oxygen tension, i.e., in the leukemia quiescent LSCs, singularly regulate the mTORC2 and its downstream effectors.
50
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen, Christopher M. Tan, Yan Kou et al. · BMC Bioinformatics · 2013 · 8.4K citations · Full text
Ensembl BioMarts: a hub for data retrieval across taxonomic space
R. J. Kinsella, Andreas Kähäri, Syed Haider et al. · Database · 2011 · 1.5K citations · Full text